This significant fat loss can create a hollowed or gaunt appearance, often referred to as Ozempic face

Zepbound and Hormonal Contraceptives: Drug Interaction Guide At a glance Drug pair / tirzepatide (Zepbound) + oral hormonal contraceptives Mechanism / delayed gastric emptying reduces oral contraceptive absorption Severity rating / moderate (per FDA labeling and Lexicomp) FDA guidance / use non-oral backup or barrier method for 4 weeks after initiation and each dose increase Affected formulations / combined oral contraceptives (COCs) and progestin-only pills Unaffected methods / patch, ring, implant, IUD, depot injection Peak gastric delay / strongest during first 1 to 4 weeks at any given dose Ethinyl estradiol Cmax reduction / ~55% after single tirzepatide dose in PK study Levonorgestrel AUC change / within bioequivalence limits but with delayed Tmax Clinical bottom line / unplanned pregnancy risk exists if no backup method is used during dose titration Why This Interaction Matters Tirzepatide is a dual GIP/GLP-1 receptor agonist approved for chronic weight management (Zepbound) and type 2 diabetes (Mounjaro)

24 HayesM
GLP-1 medications can interact with thyroid history, kidney function, and pancreatic enzymes
Individual reactions vary, and factors like dosage and diet can influence tolerability
The primary concern with any medication during lactation is whether it transfers into breast milk and, if so, whether it poses risks to the nursing infant